Il ruolo del next generation sequencing nelle leucemie acute 12 aprile 2013 Bologna Ilaria Iacobucci Dipartimento di Medicina Specialistica, Diagnostica.

Slides:



Advertisements
Similar presentations
Making Sense of Novel Prognostics: NOTCH1, SF3B1 Jennifer R Brown, MD PhD Director, CLL Center Dana-Farber Cancer Institute October 24, 2014.
Advertisements

Supervisor: VS 高志平 Reporter: R4 張妙而.  Mutations in nucleophosmin 1 ( NPM1 ) gene, one of the most common gene mutations (25%-30%) in AML  NPM1 mut co-occurs.
Genetics 101/Clinical Significance Camp Sunshine July 22, 2013 Diamond Blackfan Anemia Foundation Diamond Blackfan Anemia Canada.
Genomic DNA Variation Computer-Aided Discovery Methods Baylor College of Medicine course Term 3, 2010/2011 Lecture on Wednesday, February 2 nd,
Gene 210 Cancer Genomics April 29, Key events in investigating the cancer genome M R Stratton Science 2011;331:
Immune profiling with high-throughput sequencing Harlan Robins 1,2 Cindy Desmarais 2, Chris Carlson 1,2 Fred Hutchinson Cancer Research Center, Seattle,
Gene 210 Cancer Genomics May 5, Key events in investigating the cancer genome M R Stratton Science 2011;331:
E2A and acute lymphoblastic leukemias (ALL). A closer look at the E2A gene... Other names: TCF3, ITF1, and Factors E12/E47 Located on chromosome 19 Encodes.
Different classes of mutations – mutation detection
By: Katie Adolphsen, Robin Aldrich, Brandon Hu, Nate Havko.
Signaling and the Signal Transduction Cascade. Question?????? External Stimulus Inside cell Nucleus, Gene transcription Other cellular effects.
Safe and Effective Re-Induction of Complete Remissions in Adults with Relapsed B-ALL Using 19-28z CAR CD19-Targeted T Cell Therapy Davila ML et al. Proc.
Detection of Mutations in EGFR in Circulating Lung-Cancer Cells Colin Reisterer and Nick Swenson S. Maheswaran et al. The New England Journal of Medicine.
Genetic Mutations. Mutations What is a genetic mutation? A change in the genetic code Genetic mutations may have no effect, a beneficial effect, or a.
Multi-dimensional Genomic Profiling of Acute Leukemias Characterized by MLL gene rearrangements Eunice S. Wang MD (Medicine) and Norma J. Nowak PhD (Cancer.
COG Stephen Hunger, MD William Carroll, MD Gregory Reaman, MD Paul Bowman, MD Mini Devidas, PhD University of New Mexico Cheryl Willman,
NOTCH-1 PRE-T-CELL ACUTE LYMPHOBLASTIC LEUKEMIAS.
Large-Scale Copy Number Polymorphism in the Human Genome J. Sebat et al. Science, 305:525 Luana Ávila MedG 505 Feb. 24 th /24.
Fusion Genes in Cancer Wednesday, June 27th. Outline: Transcription Fusion genes Examples of fusion genes in cancer Summary and conclusions.
Products of haematopoiesis. Leukaemia, the current hypothesis Defect in maturation of white blood cells-may involve a block in differentiation and/or.
. Cell Division- Regulation of the Cell Cycle. Target #25-I can explain the external factors that are involved in cell cycle regulation Both external.
Acute Leukemia and the FLT3 Receptor B y: Betty Sa’ Mentor: Dr. Govind Bhagat Site: Columbia University Vanderbilt Clinic.
Normal haemopoiesis. ABNORMALITIES IN THE HEMOPOIETIC SYSTEM CAN LEAD TO HEMOGLOBINOPATHIES HEMOPHILIA DEFECTS IN HEMOSTASIS/THROMBOSIS HEMATOLOGICAL.
Next-Generation Sequencing
Here are some CML slides that may be helpful for your presentation.
MUTATIONS SC STANDARD B-4.9: The student will exemplify ways in which new characteristics are introduced into an organism or a population.
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
BIOL 445 – CANCER BIOLOGY PRESENTATION
Next-Generation Sequencing Eric Jorgenson Epidemiology 217 2/28/12.
Causes and consequences of microRNA dysregulation in cancer
Maxwell Lee National Cancer Institute Center for Cancer Research High-dimension Data Analysis Group March 19, 2014 Integrated Studies Of Breast, Esophageal,
Mutations.
Cancer Genome Landscapes
Tyrosine Kinases as Targets for Cancer Therapy Krause DS, Van Etten RA N Engl J Med 2005;353(2): Krause DS, Van Etten RA N Engl J Med 2005;353(2):
Mutations and gene regulation lecture 12-4, 12-5.
INTERPRETING GENETIC MUTATIONAL DATA FOR CLINICAL ONCOLOGY Ben Ho Park, M.D., Ph.D. Associate Professor of Oncology Johns Hopkins University May 2014.
The Genetics of Cancer Cancer: a group of 100 or more disorders that arise from alterations in genes; predominantly in somatic cells; 1 in 3 persons; from.
Recent Advances in Genomic Science Julian Sampson Institute of Medical Genetics, Cardiff.
Genomic Medicine Rebecca Tay Oncology Registrar. What is Genomic Medicine? personalised, precision or stratified medicine.
The Biology of Cancer Second Edition CHAPTER 4 Cellular Oncogenes
Leukemia Cell Study Strode Note: Meaningless title.
EUKARYOTIC CELL SIGNALING VII Abnormal Signaling in Cancer Signaling to p53 Dr. Ke Shuai Office: 9-240M Factor Tel: X69168
Signal transduction. General scheme There are two general types of receptors: cell-surface and intracellular receptors.
Emerging Genomic Technologies: Extending the Application of Genomics to Prediction, Diagnosis, Monitoring, and Early Detection Luis A. Diaz, M.D. Johns.
Samsung Genome Institute Samsung Medical Center
Neoplasia lecture4 Dr Heyam Awad FRCPath.
Molecular consequences of chromosomal rearrangements that modify the AML1/CBFβ transcription factor complex, the most frequent target of reciprocal translocations.
The Role of Notch1 signaling in T-cell acute lymphoblastic leukemia
Ingegerd Ivanov Öfverholm, MD, PhD
12- 4 Mutations.
E2A: master regulator of B-cell lymphopoiesis
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Juvenile Myelomonocytic Leukemia
What does this protein make up or do?
Chapter 17: Regulation of cell number
Cell Signaling.
Nat. Rev. Clin. Oncol. doi: /nrclinonc
MUTATIONS.
Notch1 and its role in pre-T-cell acute lymphoblastic leukemia (T-ALL)
BIOLOGY 12 Cancer.
Nat. Rev. Urol. doi: /nrurol
From Prescription to Transcription: Genome Sequence as Drug Target
(T-cell Acute Lymphoblastic Leukemia)
BMP Receptor 1a and Juvenile Polyposis Syndrome
Genome-Wide SNP Analysis in Cancer: Leukemia Shows the Way
Canonical gliomagenesis mediators EGFR, P53, and retinoblastoma protein (RB1) are important for cancer signaling. Canonical gliomagenesis mediators EGFR,
Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours By: Anh Pham.
Personalized genomic analyses for cancer mutation discovery and interpretation by Siân Jones, Valsamo Anagnostou, Karli Lytle, Sonya Parpart-Li, Monica.
Driver pathways and key genes in OSCC
Fig. 1. Schematic description of whole-exome or targeted next-generation sequencing analyses. Schematic description of whole-exome or targeted next-generation.
Presentation transcript:

Il ruolo del next generation sequencing nelle leucemie acute 12 aprile 2013 Bologna Ilaria Iacobucci Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna

Genetic characterization of BCR-ABL1 like ALL Sample IDRearrangementKey Lesions PAKTALSTRN3-JAK2IKZF1 del and p.Leu117fs PAKKCAEBF1-PDGFRBIKZF1 (IK6); EBF1 del; PAX5 inv; CDKN2A/CDKN2B del PAKVKKNUP214-ABL1IKZF1 p.Ser402fs; PAX5 del; CDKN2A/CDKN2B del e1-5 del; CDKN2A/CDKN2B del PAKYEBCR-JAK2IKZF1 (IK6); EBF1 del; PAX5 del and p.Gly24Arg; CDKN2A/CDKN2B del p.Ile682_Arg683insGlyPro; IKZF1 del e1-e6; EBF1 del; PAX5 p.Val319fs; CDKN2A/CDKN2B del (IK6); CDKN2A/CDKN2B del; FLT3 p.Asn609ins23aa p.Arg867Gln; CDKN2A/CDKN2B del PANNGLPAX5-JAK2IKZF1 del PANSFDETV6-ABL1IKZF1 (IK6); PAX5 del; CDKN2A/CDKN2B del PANEHFRCSD1-ABL1N/A SJBALL085NUP214-ABL1IKZF1 (IK6) and p.Ala79fs SJBALL010RANBP2-ABL1PAX5 del Novel rearrangements, copy number alterations, and sequence mutations constitutively activating kinase signaling and dysregulating cytokine receptor signaling. Roberts KG et al. Cancer Cell, 2012

Genetic characterization of hypodiploid ALL Near haploid Receptor tyrosine kinase signaling and Ras signaling (71%) Focal deletions of a histone gene cluster at 6p22 (19.1%) IKZF3 encoding AIOLOS (13%) Low hypodiploidy TP53 (91.2%) IKZF2 encoding HELIOS (53%) RB1 (41%) Nature Genetics 45, 242–252 (2013) Li- Fraumeni associated mutations

5 validated novel missense mutations in BCR-ABL1-positive ALL Genetic characterization of BCR-ABL1 positive ALL

Genetic characterization of T-ALL Next Generation Sequencing in T-ALL Whole genomeX chromosome targeted sequencing 12 male T-ALL cases 12 ETP ALL Inactivating mutations and deletions in the X- linked plant homeodomain finger 6 (PHF6) gene in 16% of pediatric and 38% of adult primary T-ALL sample. Vlierberghe P, Nat Genet Activating mutations in genes regulating cytokine receptor and RAS signalling (67% ); inactivating lesions disrupting haematopoietic development (58%); and histone-modifying genes (48%). Zhang G, et al. Nature 2012 Whole exome 67 T-ALL Mutations of CNOT3 7.9% adult T-ALLs; mutations affecting the ribosomal proteins RPL5 and RPL10 in 9.8% pediatric T-ALLs. De Keersmaecker K. Nature Genetics, 2013 Whole exome 5 T-ALL Mutations in NT5C2, which encodes a 5′- nucleotidase enzyme that is responsible for the inactivation of nucleoside-analog chemotherapy drugs. Tsoneva G. Nature Medicne, 2013

Minimal residual disease monitoring and NGS in ALL Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia Faham M et al. Blood 2012;120: High-Throughput Sequencing Detects Minimal Residual Disease in Acute T Lymphoblastic Leukemia Wu D et al. Sci Transl Med 2012 Minimal residual disease monitoring and NGS in ALL